stoxline Quote Chart Rank Option Currency Glossary
  
CONMED Corporation (CNMD)
68.9  1.12 (1.65%)    07-12 15:04
Open: 68.4
High: 69.22
Volume: 123,499
  
Pre. Close: 67.78
Low: 67.59
Market Cap: 2,122(M)
Technical analysis
2024-07-12 2:51:02 PM
Short term     
Mid term     
Targets 6-month :  85.07 1-year :  91.78
Resists First :  72.83 Second :  78.58
Pivot price 67.26
Supports First :  63.54 Second :  52.87
MAs MA(5) :  66.41 MA(20) :  67.89
MA(100) :  74.49 MA(250) :  92.75
MACD MACD :  -1.6 Signal :  -1.7
%K %D K(14,3) :  54.7 D(3) :  32.9
RSI RSI(14): 49.2
52-week High :  135.35 Low :  61.04
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CNMD ] has closed below upper band by 19.6%. Bollinger Bands are 47.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 69.11 - 69.38 69.38 - 69.69
Low: 65.58 - 65.86 65.86 - 66.18
Close: 67.25 - 67.71 67.71 - 68.23
Company Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Headline News

Wed, 10 Jul 2024
Jennison Associates LLC Acquires 4,321 Shares of CONMED Co. (NYSE:CNMD) - Defense World

Tue, 09 Jul 2024
Capstone Investment Advisors LLC Acquires New Position in CONMED Co. (NYSE:CNMD) - Defense World

Tue, 09 Jul 2024
CONMED Co. (NYSE:CNMD) Shares Sold by State of Alaska Department of Revenue - Defense World

Mon, 08 Jul 2024
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024 - StockTitan

Sun, 30 Jun 2024
A Note On CONMED Corporation's (NYSE:CNMD) ROE and Debt To Equity - Yahoo Finance

Thu, 27 Jun 2024
Here's Why You Should Retain CONMED (CNMD) Stock for Now - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 31 (M)
Shares Float 31 (M)
Held by Insiders 0.5 (%)
Held by Institutions 116.8 (%)
Shares Short 3,880 (K)
Shares Short P.Month 3,660 (K)
Stock Financials
EPS 2.6
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 27.76
Profit Margin 6.5 %
Operating Margin 9.6 %
Return on Assets (ttm) 3.6 %
Return on Equity (ttm) 10.2 %
Qtrly Rev. Growth 5.6 %
Gross Profit (p.s.) 0
Sales Per Share 40.9
EBITDA (p.s.) 6.7
Qtrly Earnings Growth 956.7 %
Operating Cash Flow 158 (M)
Levered Free Cash Flow 168 (M)
Stock Valuations
PE Ratio 26.38
PEG Ratio 0.6
Price to Book value 2.48
Price to Sales 1.68
Price to Cash Flow 13.39
Stock Dividends
Dividend 0.2
Forward Dividend 0
Dividend Yield 0.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android